Innate Pharma (IPHA) Debt to Equity (2017 - 2025)
Innate Pharma posted quarterly Debt to Equity of -$1.04 for Q4 2025, down 129.64% year-on-year from $3.51 in Q4 2024, and down 119.79% on a QoQ basis from $5.25 in Q2 2025.
Innate Pharma (IPHA) has 9 years of Debt to Equity data on file, last reported at -$1.04 in Q4 2025.
- For the quarter ending Q4 2025, Debt to Equity fell 129.64% year-over-year to -$1.04; the trailing twelve-month figure through Dec 2025 stood at -$1.04 (down 129.64% YoY), and the FY2025 full-year result was -$1.04, down 129.64% from the prior year.
- Debt to Equity for Q4 2025 stood at -$1.04, down from $5.25 in the prior quarter.
- Across five years, Debt to Equity topped out at $5.25 in Q2 2025 and bottomed at -$1.04 in Q4 2025.
- The 5-year median for Debt to Equity is $0.74 (2023), against an average of $1.21.
- The widest annual swing landed in 2024, when Debt to Equity surged 356.47%; it then slumped 129.64% in 2025.
- A 5-year view of Debt to Equity shows it stood at $0.41 in 2021, then surged by 89.44% to $0.78 in 2022, then dropped by 1.49% to $0.77 in 2023, then jumped by 356.47% to $3.51 in 2024, then plunged by 129.64% to -$1.04 in 2025.
- The last three Debt to Equity figures came in at -$1.04 (Q4 2025), $5.25 (Q2 2025), and $3.51 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 0.06 |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Innate Pharma | 199.64 Mn | 199.64 Mn | - | -1.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.04 |
| Jun 30, 2025 | 5.25 |
| Dec 31, 2024 | 3.51 |
| Jun 30, 2024 | 1.23 |
| Dec 31, 2023 | 0.77 |
| Jun 30, 2023 | 0.70 |
| Dec 31, 2022 | 0.78 |
| Jun 30, 2022 | 0.37 |
| Dec 31, 2021 | 0.41 |
| Jun 30, 2021 | 0.12 |
| Dec 31, 2020 | 0.12 |
| Jun 30, 2020 | 0.09 |
| Dec 31, 2019 | 0.09 |
| Dec 31, 2018 | 0.03 |
| Dec 31, 2017 | 0.07 |